The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether meglitinides changes hypoglycaemic episodes a) Non‐serious hypoglycaemia compared with sulphonylureas (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Obesity Class II leads to higher mortality(in‐hospital) compared with normal Weight or Non‐Obese (high certainty).
Obesity Class II leads to higher mechanical ventilation(in‐hospital) compared with normal Weight or Non‐Obese (high certainty).
Obesity Class II may leads to higher ICU admission(in‐hospital) compared with normal Weight or Non‐Obese (low certainty).
Obesity Class II probably leads to higher hospitalisation(30‐days, community) compared with normal Weight or Non‐Obese (moderate certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Obesity Class III may leads to higher mortality(in‐hospital) compared with normal BMI, Non‐obese, or BMI < 40 (low certainty).
Obesity Class III leads to higher mechanical ventilation(in‐hospital) compared with normal BMI, Non‐obese, or BMI < 40 (high certainty).
Obesity Class I leads to higher mortality(in‐hospital) compared with normal Weight or Non‐Obese (high certainty).
Obesity Class III probably leads to higher ICU admission (adjusted for at least DM, HTN, cardiovascular… compared with normal BMI, Non‐obese, or BMI < 40 (moderate certainty).
Obesity Class III may leads to higher hospitalisation (adjusted for DM, HTN, cardiovascular disease, age,… compared with normal BMI, Non‐obese, or BMI < 40 (low certainty).
Obesity Class III may leads to higher ICU admission (in‐hospital) compared with normal BMI, Non‐obese, or BMI < 40 (low certainty).